Maximilian J Mair Selected Research

Maximilian J Mair Research Topics

13	Neoplasms (Cancer) 05/2024 - 01/2021
5	Meningioma (Meningiomas) 05/2024 - 11/2020
4	Glioma (Gliomas) 01/2024 - 11/2020
4	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 11/2020
4	Brain Neoplasms (Brain Tumor) 01/2023 - 12/2021
3	COVID-19 02/2023 - 01/2022
3	Inflammation (Inflammations) 12/2021 - 11/2020
2	Infections 02/2023 - 01/2022
1	Thyroid Diseases (Thyroid Disease) 05/2024
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2024
1	Prostatic Neoplasms (Prostate Cancer) 05/2024
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Oligodendroglioma 10/2022
1	Hematologic Neoplasms (Hematological Malignancy) 02/2022
1	Fatigue 01/2022
1	Hyperthyroidism 10/2021
1	Brain Diseases (Brain Disorder) 06/2021
1	Seizures (Absence Seizure) 06/2021
1	Neoplasm Metastasis (Metastasis) 11/2020

3	AntibodiesIBA 05/2024 - 01/2021
2	LigandsIBA 05/2024 - 11/2020
1	Radioisotopes (Radionuclides)IBA 05/2024
1	Amino Acids FDA Link 01/2024
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	trastuzumab deruxtecanIBA 01/2023
1	depatuxizumab mafodotinIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	tixagevimabIBA 11/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 11/2022
1	cilgavimabIBA 11/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2022
1	TrabectedinIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Bevacizumab (Avastin)FDA Link 12/2021
1	Thyroid HormonesIBA 10/2021
1	Chimeric Antigen ReceptorsIBA 06/2021
1	Bispecific AntibodiesIBA 06/2021
1	Immune Checkpoint InhibitorsIBA 05/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	VaccinesIBA 01/2021
1	AlbuminsIBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	Death Domain ReceptorsIBA 11/2020
1	Edetic Acid (EDTA)FDA Link 11/2020